Top-News
Biotechnologie Belgien

UCB SA Aktie

Aktie
WKN:  852738 ISIN:  BE0003739530 US-Symbol:  UCBJF
172,05 €
+10,20 €
+6,30%
17:01:04 Uhr
Depot/Watchlist
Aktienanzahl *
189,72 Mio.
Marktkapitalisierung *
30,71 Mrd. €
Streubesitz
25,08%
Index-Zugehörigkeit
BEL 20
IR-Website
zur Website
*Stand: 25.11.2024
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,22: MK5UZ6
Werbung

UCB SA News

21.03.25 - GlobeNewswire
UCB Convening Notice to the General Meeting of the Shareholders 2025
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders to the ordinary general meeting of the shareholders (the “ ...
02.12.24 - BNP Paribas
LVMH, Gilead, Merck, Vistra, Coupang und viele mehr - Charttechnik mit Harald Weygand
Heute geht es in der Sendung „Rendezvous mit Harry“ um Aktien, „die es in sich haben“, so Trader Harald Weygand. Im Einzelnen sind das: LVMH, Gilead Sciences, Alcoa, Merck, ...
09.09.24 - PR Newswire
New insights highlight unmet needs for people living with Lennox-Gastaut syndrome and significant burden of the disease
New insights highlight unmet needs for people living with Lennox-​Gastaut syndrome and significant burden of the disease PR Newswire
22.03.24 - GlobeNewswire
UCB Convening Notice to the General Meeting of the Shareholders 2024
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS
28.02.24 - wallstreetONLINE Redaktion
Was heute wichtig wird: Frische Zahlen vom BVB, Salesforce, Uniper und Apple hält HV ab
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
24.03.23 - GlobeNewswire
UCB Convening Notice to the General Meeting of theShareholders 2023
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the general meeting of shareholders (the “ General ...
25.03.22 - GlobeNewswire
UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022
*** Unofficial English translation – For convenience purposes only ***
02.12.21 - dpa-AFX
Novartis und belgische UCB entwickeln gemeinsam Parkinson-Therapien
Novartis hat sich mit der belgischen UCB zusammengetan, um die Forschung an möglichen Therapien der Parkinson-​Krankheit voranzutreiben. Dies teilte der Pharmakonzern am ...
19.10.21 - Börse Online
Innovationsaktie der Woche: UCB - Solides Wachstum, starke Innovation und Aktie vor einer wichtigen Marke
Der belgische Pharmakonzern hat seine Innovationskraft in den vergangenen 3 Jahren stetig gesteigert, genauso wie Umsätze und Gewinne. Jetzt steht die Aktie vor einer wichtigen ...
22.07.21 - Payoff
UCB - belgischer Blue Chip erwacht
Die Aktien des belgischen Pharma- und Biotechnologieunternehmen UCB vermochten im Juni, den Abwärtstrend nach oben zu durchbrechen und befinden sich seither im ...
26.03.21 - GlobeNewswire
UCB SA/NV - Convening notice annual shareholders meeting
*** Unofficial English translation – For convenience purposes only ***
29.07.20 - PR Newswire
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease PR Newswire
29.07.20 - PR Newswire
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease PR Newswire
27.07.20 - PR Newswire
UCB Half Year Report 2020
UCB Half Year Report 2020 UCB's resilient product portfolio drives continued company growth PR Newswire
27.07.20 - PR Newswire
UCB Half Year Report 2020
UCB Half Year Report 2020 PR Newswire
05.06.20 - PR Newswire
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy - Underlines UCB's ...
05.06.20 - PR Newswire
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy PR Newswire
01.04.20 - PR Newswire
ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million PR Newswire
27.03.20 - GlobeNewswire
UCB SA/NV : Convening notice to the general meeting of shareholders
*** Unofficial English translation – For convenience purposes only ***  UCB SA/NV - Public Limited Liability Company Allée de la Recherche 60, 1070 Brussels Enterprise nr. ...
06.03.20 - PR Newswire
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million PR ...

Newssuche

Videos

newspaper
30.04.25 +13,48%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »